Eligibility: Investigators within the first SIX years of their first independent faculty position and in the following series are eligible: In Line, In Residence, Adjunct, Clinical-X, Clinical and Researcher. Awardees may not hold a competitive grant from a national agency (e.g. NIH, ACS etc.) or be a previous recipient of an ACS-IRG seed grant. Investigators who hold funds from the UCRI Cancer Research Coordinating Committee (CRCC) or any award where the majority of the funds are for the express purpose of supporting the investigator’s salary (such as the NIH K series) are eligible. Investigators whose initial nationally competitive research grant was not renewed are also eligible as long as other criteria are met and that they are not in a no cost extension. Cancer Center membership is not required. US citizenship or Permanent Residency Status is required. Questions regarding these criteria should be forwarded to Edward Nelson email@example.com and cc: firstname.lastname@example.org
Revised applications are accepted. However, applicants submitting revised applications are required to address the previous submission critiques in detail in no more than two pages, which are subject to the same border and font constraints as the application. The response to the critiques does not count towards the page limits for the revised application proper. We strongly recommend that the applicants address critiques individually from each reviewer.
Applicants who are writing a grant for the first time are encouraged to consult a senior colleague in their field